Full Press Release Details
Health Canada Accepts New Drug Submission for Lecanemab as Treatment for Early Alzheimer’s Disease.
BIIB
Health Canada Accepts New Drug Submission for Lecanemab as Treatment for Early Alzheimer’s Disease
Key Takeaway: Health Canada Accepts New Drug Submission for Lecanemab as Treatment for Early Alzheimer’s Disease